Company news

Cerus Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021

July 19, 2021

Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets

July 13, 2021

Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT® Fibrinogen Complex

June 29, 2021

Cerus Corporation Celebrates World Blood Donor Day 2021

June 13, 2021

Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets

May 16, 2021

Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance

May 3, 2021

Cerus Corporation to Release First Quarter 2021 Financial Results on May 4, 2021

April 19, 2021

Cerus Corporation to Participate in Jefferies Virtual Global Plasma Summit

March 2, 2021

Cerus Corporation Announces Record Fourth Quarter and Full Year 2020 Financial Results

February 24, 2021

Cerus Corporation and Shandong Zhongbaokang Medical Implements Partner to Establish Joint Venture in China

February 23, 2021

Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

February 10, 2021

Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product Revenue

January 10, 2021

Cerus’ Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets

December 14, 2020

Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting

December 3, 2020

Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation

November 29, 2020

Cerus Corporation Announces Record Third Quarter 2020 Results

October 28, 2020

Cerus Corporation to Release Third Quarter 2020 Financial Results on October 29, 2020

October 18, 2020

Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Blood

October 12, 2020

Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual Meeting

September 27, 2020

Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch

August 6, 2020

Cerus Corporation Announces Record Second Quarter 2020 Results

August 3, 2020

Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems

July 29, 2020

Cerus Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020

July 22, 2020

Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma

July 6, 2020

Cerus Corporation Celebrates World Blood Donor Day

June 11, 2020

Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex

May 25, 2020

Cerus Corporation Announces First Quarter 2020 Results

May 4, 2020

Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits

May 3, 2020

Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020

April 23, 2020

Cerus Corporation Announces Expansion of BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells

April 19, 2020

Cerus Corporation Provides Update on COVID-19 Related Activities

April 5, 2020

University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent Plasma

April 1, 2020

Cerus Corporation Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Preparation of COVID-19 Convalescent Plasma

April 1, 2020

Cerus Forms Group to Research Optimal Production of COVID-19 Convalescent Plasma

March 25, 2020

Cerus Corporation Announces Strategic Organizational Changes

March 1, 2020

Cerus Corporation Announces Record Fourth Quarter and Full Year 2019 Financial Results

February 19, 2020

U.S. Department of Defense Awards Funding for Study to Evaluate the Use of INTERCEPT Plasma in Traumatic Burn Resuscitation

February 17, 2020

Cerus Corporation to Release Fourth Quarter and Full Year 2019 Financial Results on February 20, 2020

February 11, 2020

Cerus Corporation Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

January 30, 2020

Cerus Corporation Announces Pricing of Upsized Public Offering of Common Stock

January 28, 2020

Cerus Corporation Announces Public Offering of Common Stock

January 27, 2020

Coronavirus Inactivation Reported in Recent INTERCEPT Blood System Publication in Transfusion Medicine

January 22, 2020

French Hemovigilance Report Highlights Safety and Effectiveness of INTERCEPT Platelets During First Full Year of 100% Production and Routine Use

January 20, 2020

Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2019 Product Revenue

January 12, 2020

Cerus Corporation Announces New Five-Year INTERCEPT Blood System Agreement With Swiss Transfusion SRC

December 11, 2019

Cerus Corporation to Present at the Stifel 2019 Healthcare Conference

November 12, 2019

Cerus Corporation to Present at the Stephens Nashville Investment Conference

November 7, 2019

Cerus Corporation Announces Third Quarter 2019 Results

October 29, 2019

Cerus Corporation to Release Third Quarter 2019 Results and to Discuss Recent FDA Guidance for Bacterial Safety of Platelets on October 30, 2019

October 20, 2019

Cerus Corporation Announces Schedule of Presentations at the 2019 AABB Annual Meeting

October 17, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks